Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

14.86
Delayed Data
As of Feb 12
 -1.08 / -6.78%
Today’s Change
10.56
Today|||52-Week Range
22.00
-9.33%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close15.94
Today’s open16.11
Day’s range14.35 - 16.11
Volume153,063
Average volume (3 months)198,115
Market cap$562.3M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)+24.26%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+5,071.68%
P/E ratioNM
Price/Sales40.54
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+1.08+7.06%
SRPTSarepta Therapeutics...+0.62+5.29%
SCMPSucampo Pharmaceutic...+0.08+0.67%
EPZMEpizyme Inc+0.64+7.19%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$11.7M
Annual profit (last year)-$237.0M
Net profit margin-2,028.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts

Partner Offers